Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer

BACKGROUND: We sought to determine the prognostic value of pathologic response to neoadjuvant chemotherapy with concurrent trastuzumab. PATIENTS AND METHODS: Two hundred and twenty-nine women with HER2/neu (HER2)-overexpressing breast cancer were treated with neoadjuvant chemotherapy plus trastuzuma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, M. M., Allen, P., Gonzalez-Angulo, A. M., Woodward, W. A., Meric-Bernstam, F., Buzdar, A. U., Hunt, K. K., Kuerer, H. M., Litton, J. K., Hortobagyi, G. N., Buchholz, T. A., Mittendorf, E. A.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2013
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3718505/
https://ncbi.nlm.nih.gov/pubmed/23562929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt131
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados